USPTO serial 97677741
IO9
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- FERRELL, LUCY K
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with IO9?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
La Jolla, CA
La Jolla, CA
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
John L. Slafsky
John L. Slafsky WILSON SONSINI GOODRICH & ROSATI650 PAGE MILL ROADPALO ALTO, CA 94304United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Biological and chemical preparations for the prevention and treatment of cancer; Pharmaceutical products, preparations, and compounds for the prevention and treatment of cancer and tumors; Medical reagents; Diagnostic kits comprised of medical diagnostic reagents, assays for testing of bodily fluids for use in disease detection, namely, cancer; stem cells, protein arrays, and molecular compounds for medical purposes; Pharmaceutical preparations for use in oncology; Antitumor drugs in the nature of pharmaceutical preparations | ACTIVE | — |
| 009 | Downloadable computer software for detecting and treating cancer using artificial intelligence (AI) | ACTIVE | — |
| 042 | Software as a service (saas) services featuring software for detecting and treating cancer using artificial intelligence (AI); Development of pharmaceutical preparations and medicines; Drug discovery services; Medical research in the field of cancer; Pharmaceutical research and development services; Research and development of pharmaceuticals for the treatment of cancer; medical and scientific research, namely, conducting clinical trials for others; DNA screening and analysis services for scientific research purposes | ACTIVE | — |
| 044 | Medical services for the treatment and detection of cancer; Medical analysis services using artificial intelligence (AI) for the diagnosis of cancer; Providing cancer screening services; Providing a website via a global computer network featuring information in the fields of health, cancer, cancer treatment, recovery and survival, and artificial intelligence use in medicine; RNA or DNA analysis for cancer diagnosis and prognosis | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by io9, LLC
- Other trademarks owned by io9, LLC
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named IO9
- Prosecution event MAB6 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 14, 2025 | MAB6 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Jul 14, 2025 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Mar 3, 2025 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Dec 2, 2024 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Dec 2, 2024 | EXT2 | SOU EXTENSION 2 FILED | — |
| Dec 2, 2024 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jun 11, 2024 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Jun 11, 2024 | EXT1 | SOU EXTENSION 1 FILED | — |
| Jun 11, 2024 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Dec 12, 2023 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Oct 17, 2023 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Oct 17, 2023 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 27, 2023 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Sep 12, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 12, 2023 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Sep 12, 2023 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Sep 12, 2023 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Sep 12, 2023 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Sep 7, 2023 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 7, 2023 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 7, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 29, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 6, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Nov 18, 2022 | NWAP | NEW APPLICATION ENTERED | — |